Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019
Headlines have led to outside-the-box thinking as well as a more global perspective in preventing CV disease and events.
Related Articles
Fellows 2025
Sign Up for Our Newsletter Get the latest news and updates from TCTMD. Forgot Your Password? Enter the email you used to register to reset…
Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding
The advantage of apixaban was consistent across a variety of subgroups and confirms earlier observations.
Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity
At this early age, metabolism is already dysregulated and lifestyle changes are warranted to prevent future disease.
Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA
Trialists should focus less on physician-defined outcomes and more on what matters to patients, Mario Gaudino says.
Actioning the Data: Earlier AS Referral in the Real World
Bernard Prendergast and Jordan Strom discuss the evolution of AS referral and how earlier treatment impacts patient outcomes.
The EARLY TAVR Trial: Best Practices for Referrer and Patient Engagement
Philippe Généreux, Brad Oldemeyer, and Jennifer Daniel share their experiences treating asymptomatic aortic stenosis patients in the EARLY TAVR trial.
Poor Cardiometabolic Health in Pregnancy Tied to Higher BP for Young Offspring
The early impact of gestational diabetes, hypertensive disorders of pregnancy, and obesity appears to grow as kids age.
Quick Takes: Marwan Saad on the Clinical Implications of PROTECTED TAVR
Use of embolic protection declined—but didn’t disappear—in the US after the trial’s findings. Marwan Saad, MD, PhD, explains the data.
Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery
When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed.
CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women
The findings highlight the importance of rheumatology, cardiology, and primary care working together to intervene early.